Xenon Pharmaceuticals | DEF 14A: Definitive information statements
Apr 26 16:31 ET
Xenon Pharmaceuticals | ARS: Annual Report to Security Holders
Apr 26 16:30 ET
Xenon Pharmaceuticals | 8-K: Current report
Apr 19 16:26 ET
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Von Seggern Christopher
Mar 12 18:44 ET
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer AULIN SHERRY
Mar 12 18:44 ET
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KENNEY CHRISTOPHER JOHN
Mar 12 18:44 ET
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer EMPFIELD JAMES R.
Mar 12 18:39 ET
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN SHERRINGTON
Mar 12 18:39 ET
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DiFabio Andrea
Mar 12 18:39 ET
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer MORTIMER IAN
Mar 12 18:34 ET
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GAROFALO ELIZABETH A.
Mar 11 20:13 ET
Xenon Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 8 18:51 ET
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN SHERRINGTON
Mar 8 17:36 ET
Xenon Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GANNON STEVEN
Mar 8 17:32 ET
Xenon Pharmaceuticals | 8-K: Current report
Mar 8 17:31 ET
Xenon Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 7 19:06 ET
Xenon Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 7 19:06 ET
Xenon Pharmaceuticals | 10-K: Annual report
Feb 29 22:33 ET
Xenon Pharmaceuticals | 8-K: Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Feb 29 16:16 ET
Xenon Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(7.7%),Behzad Aghazadeh(7.7%)
Feb 14 09:17 ET
No Data
No Data